Stay updated with breaking news from Efficacy Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Synapse Biomedical, Inc. announced today that the FDA has granted premarket approval (PMA) of the NeuRx® Diaphragm Pacing System (NeuRx DPS®)...
Announced interim safety and efficacy data for ADI-001 in ongoing Phase 1 study for the potential treatment of relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL); Next data update expected in Q2 2023Announced preclinical data for differentiated chimeric antigen receptor (CAR) and chimeric adaptor (CAd) progr...
But then you ask, where is the efficacy data? is there any proof that in any demographic this is necessary, effective, and save? we know for young healthy adults, men especially, there is a one in 5,000 chance of myocarditis, or a serious adverse event. but where is the benefit to counteract that? if you have all risk and no benefit, literally doing? i think the government has been very opaque with the safety data. we know that the fda's own advisory committee members have complained about that. they need to be transparent and release the data. >> trace: i want to put this on the screen, this ...
/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...
TAK-003 Recommended for the Prevention of Dengue Disease Caused by Any Dengue Virus Serotype in Individuals Four Years of Age and Older in the EU and in Dengue-Endemic Countries Participating in